乳腺癌后劳动力市场依恋的社会经济差异:基于人口的匹配队列研究
Cathrine F Hjorth1, István Bakos2, Deirdre Cronin-Fenton2
1Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark. cfh@clin.au.dk.
概括
乳腺癌幸存者经历了长期的劳动力市场挑战,特别是那些患有晚期疾病或较低社会经济地位的人. 然而,在高资源的幸存者中,相对影响最大,突出了恢复的差异.
科学领域:
- 公共卫生 公共卫生
- 在瘤学瘤学.
- 社会学 社会学 社会学
背景情况:
- 乳腺癌幸存者在维持劳动力市场依恋方面面临重大挑战.
- 之前的研究往往排除了非就业女性,限制了人口层面的洞察力.
- 根据社会经济群体和疾病阶段对劳动力市场依附的长期公共卫生影响尚不清楚.
研究的目的:
- 为了比较乳腺癌幸存者的劳动力市场依恋模式与普通人口.
- 研究社会经济因素和疾病阶段对这些模式的影响.
- 提供与人口相关的关于乳腺癌长期后果的证据.
主要方法:
- 利用丹麦的登记册,确定了13,443名乳腺癌幸存者 (I-III阶段) 和134,430名匹配的对照 (2002-2018).
- 在诊断后的10年内评估病假,劳动力分离和残疾养老金.
- 采用负二项式回归,按阶段,教育,同居和社会脆弱性指数 (rSVI) 分层.
主要成果:
- 与对照组相比,幸存者通常具有高等教育,伴侣和较低的RSVI.
- 最初,幸存者出现了较高的病假率,但较低的劳动力离职率和残疾养老金率.
- 从第三年开始,所有结果在幸存者中略高,在那些处于先进阶段和较低社会经济地位的人群中,劳动力分离和残疾养老金的比例较高.
- 相对影响在高资源幸存者 (伴侣,高等教育,较低的RSVI) 中最大.
结论:
- 这项研究提供了关于乳腺癌的长期公共卫生后果的相关证据,包括非就业的幸存者.
- 先进阶段和较低的社会经济地位与更高的劳动力分离和残疾养老金有关.
- 高资源的幸存者经历了最大的相对影响,这表明恢复和重新融入的差异.
相关概念视频
01:21Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
01:20Comparing the Survival Analysis of Two or More Groups
621
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
621
02:20Longitudinal Research
13.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.5K
01:29Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
01:25Statistical Methods for Analyzing Epidemiological Data
1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K
01:24Kaplan-Meier Approach
643
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
643